Skip to main content

Table 2 KRAS mutation frequencies observed in borderline malignancies

From: KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay

  borderline
histotype n mutated % mutated
serous 20 7 35.00
endometroid 1 0 0.00
mucinous 6 3 50.00
unknown 2 0 0.00
total 29 10 34.48